buy medicine online indiamedicine onlineloading...

    Ado-trastuzumab emtansine

    Information about Ado-trastuzumab emtansine

    Ado-trastuzumab emtansine uses

    Ado-trastuzumab emtansine is used in the treatment of breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines.

    How ado-trastuzumab emtansine works

    Ado-trastuzumab emtansine is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body's immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.

    Common side effects of ado-trastuzumab emtansine

    Tiredness, Nausea, Musculoskeletal (bone, muscle or joint) pain, Bleeding, Low blood platelets, Headache, Liver disorder, Constipation, Nosebleeds
    Content Details
    Written By
    Dr. Anuj Saini
    Reviewed By
    Dr. Ashish Ranjan
    MD (Pharmacology), MBBS
    Last updated on:
    21 Jun 2019 | 06:09 PM (IST)
    Want to know more?
    Read Our Editorial Policy

    Available Medicine for Ado-trastuzumab emtansine

    • ₹155585 to ₹248937
      Roche Products India Pvt Ltd
      2 variant(s)

    Frequently asked questions for Ado-trastuzumab emtansine

    Ado-trastuzumab emtansine

    Q. What is the use of Ado-trastuzumab emtansine?

    Ado-trastuzumab emtansine is used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab and a taxane.

    Q. How is Ado-trastuzumab emtansine different?

    Ado-trastuzumab emtansine is a conjugate of the HER2 directed trastuzumab and a highly toxic microtubule-targeted drug (emtansine). Thus it is made up of 2 cancer-fighting agents in 1 medicine- The monoclonal antibody trastuzumab and a chemotherapy emtansine. Ado-trastuzumab emtansine brings chemotherapy medicine (emtansine) into HER2-positive cells and kills them. It is designed to cause less harm to normal cells.

    Content on this page was last updated on 21 June, 2019, by Dr. Varun Gupta (MD Pharmacology)